| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/03/2002 | CN1342769A Polypeptide-matric metalloprotease cysteine switch 10.78 and polynucleotide for coding it |
| 04/03/2002 | CN1342768A Polypeptide-dipeptidyl peptidase IV protein 27.5 and polynucleotide for coding it |
| 04/03/2002 | CN1342767A Polypeptide-human phosphatidase 10.67 and polynucleotide for coding it |
| 04/03/2002 | CN1342766A Polypeptide-phosphatidase A2-18.59 and polynucleotide for coding it |
| 04/03/2002 | CN1342765A Polypeptide-human receptor associated tyrosine kinase 8.91 and polynucleotide for coding it |
| 04/03/2002 | CN1342764A Polypeptide-tRNA guanine glycotransferase 24.75 and polynucleotide for coding it |
| 04/03/2002 | CN1342763A Polypeptide-colipase 9.79 and polynucleotide for coding it |
| 04/03/2002 | CN1342762A Polypeptide-human protein 32.67 containing enoyl-CoA hydratase characteristic sequence fragment and polynucleotide for coding it |
| 04/03/2002 | CN1342761A Polypeptide-phosphoglyceromutase 10.56 and polynucleotide for coding it |
| 04/03/2002 | CN1342760A Polypeptide-threonine synthetase 13.75 and polynucleotide for coding it |
| 04/03/2002 | CN1342759A Polypeptide-human reverse transcriptase 12.76 and polynucleotide for coding it |
| 04/03/2002 | CN1342758A Polypeptide-reverse transcriptase 9.24 and polynucleotide for coding it |
| 04/03/2002 | CN1342757A Polypeptide-human threonine-tRNA synthetase 16.83 and polynucleotide for coding it |
| 04/03/2002 | CN1342756A Calcitonin gene related peptide gene synthesized by plant preferable codon and its application in plant |
| 04/03/2002 | CN1342713A Human macrobiosis-ensuring protein and its coding sequence and application |
| 04/03/2002 | CN1342710A Polypeptide-human rhombus associated protein 48-35.53 and polynucleotide for coding it |
| 04/03/2002 | CN1342678A Polypeptide-insulin-like growth factor binding 10.45 and polynucleotide for coding it |
| 04/03/2002 | CN1342673A Polypeptide-transcription factor XAP-2 protein 49.72 and polynucleotide for coding it |
| 04/03/2002 | CN1342494A Ear drops for repairing ear membrane |
| 04/03/2002 | CN1342493A IL6/IL2 fusion protein method for inducing differentiation of chronic granulocytic leukemia |
| 04/03/2002 | CN1082043C Novel cationic lipids and the use thereof |
| 04/03/2002 | CA2358380A1 Testis-specific gene |
| 04/02/2002 | US6365796 Transgenic UCP2 knockout mouse and use thereof |
| 04/02/2002 | US6365730 Nucleotide sequence; viricides |
| 04/02/2002 | US6365726 Polynucleotides encoding IL-1 Hy2 polypeptides |
| 04/02/2002 | US6365725 DNA coding for a human vasoconstrictive peptide and use thereof |
| 04/02/2002 | US6365722 Nucleic acid encoding an i-kappa-b kinase binding protein of defined amino acid sequence; antinflammatory agents; immunosuppressants |
| 04/02/2002 | US6365716 Binds to epitope of polypeptide having defined amino acid sequence; antitumor agents |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365713 Low density lipoprotein receptor produced in culture; viricides |
| 04/02/2002 | US6365712 Isolated soluble cd antigen; diagnosis and treatment of related disorders |
| 04/02/2002 | US6365711 Methods and reagents for modulating TGF-β superfamily signalling |
| 04/02/2002 | US6365630 Compositions and methods for inhibiting photoaging of skin |
| 04/02/2002 | US6365619 Cyclic oligopeptide vcam-1 inhibitor; (s)-.beta.-(3-methoxypropyl) ((4-((2-methylphenylaminocarbonylamino)-phenyl) acetyl)amino)acetyl-amino-3,4-dimethoxy-benzenepropanoic acid |
| 04/02/2002 | US6365592 For therapy of diabetes, glucose intolerance, insulin resistance, and obesity |
| 04/02/2002 | US6365576 Topically administering to the cornea a dna sequence that encodes interferon .alpha.1, and a promoter operatively linked to the dna sequence; wherein promoter induces constitutive expression of dna sequence |
| 04/02/2002 | US6365575 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 04/02/2002 | US6365573 Regulation of neural enzymes |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365571 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient |
| 04/02/2002 | US6365570 Administering in unit dosage form of a peptide comprising serum amyloid p component or at least one endotoxin-binding fragment thereof, effective to neutralize lipopolysaccharide in an animal or patient thus treated |
| 04/02/2002 | US6365569 To protect animals from diseases caused by parasitic helminths |
| 04/02/2002 | US6365405 Compositions of chondrocytes, preparation and utilization |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365396 Parasite-derived resistance |
| 04/02/2002 | US6365395 Process for removing protein aggregates and virus from a protein solution |
| 04/02/2002 | US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators |
| 04/02/2002 | US6365392 Amino acid sequences; anthelmintics; nematocides; vaccines; for veterinary medicine |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365387 fabG |
| 04/02/2002 | US6365374 2′-deoxy-2′-alkylnucleotide containing nucleic acid |
| 04/02/2002 | US6365373 Which have tyrosine kinase receptor c (trkc)-binding activity and trkc-signal inducing activity; nucleic acids, expression vectors, host cells; treating diabetic peripheral neuropathy |
| 04/02/2002 | US6365372 Amino acid sequence of protein with atpase (adenosine triphosphatase) activity; viricides; antibodies; probes; primers; antisense agents |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365369 Polynucleotide which encodes a specific amino acid sequence; diagnosis and therapy of urogenital disorders |
| 04/02/2002 | US6365365 Method of determining whether an agent modulates glycosyl sulfotransferase-3 |
| 04/02/2002 | US6365360 Methods of identifying modulators of human IP prostaglandin receptor |
| 04/02/2002 | US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein |
| 04/02/2002 | US6365358 Polypeptide of defined amino acid sequence; diagnosis, prevention and treatment of cancer, developmental, autoimmune and nervous system disorders; anticarcinogenic agents; antiinflammatory agents |
| 04/02/2002 | US6365357 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein |
| 04/02/2002 | US6365354 Antisense modulation of lysophospholipase I expression |
| 04/02/2002 | US6365351 Non-invasive method for detecting target RNA |
| 04/02/2002 | US6365348 Obtaining biological sample, generating cdna, contacting with oligonucleotide primers of defined nucleotide sequence in polymerase chain reaction, detecting amount of cdna sequence that amplifies; using predetermined cut-off value |
| 04/02/2002 | US6365343 Treating rhinovirus infection by using insufflate for nasal administration composed of soluble interacellular adhesion molecule, type i; a bulking agent; and carboxymethyl cellulose, sodium salt |
| 04/02/2002 | US6365342 Methods for detecting anti-viral activity of calcium-dependent lectins |
| 04/02/2002 | US6365218 Xanthan gum hydrocolloid |
| 04/02/2002 | US6365208 Formulation comprising lactase mixture, microcrystalline cellulose, mannitol, effective amount of lubricant to aid compression; storage stability |
| 04/02/2002 | US6365190 Preparing aqueous solution of hydrophilic component and organic solution of hydrophobic component, delivering solutions to atomizer separately, atomizing together to produce droplets containing both components, spray drying |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 04/02/2002 | US6365177 Insulin supplemented infant formula |
| 04/02/2002 | US6365165 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
| 04/02/2002 | US6365164 Injecting therapeutic amount of botulinum toxin into prostate gland of patient, thereby alleviating symptoms of prostatic hyperplasia, benign prostatic hyperplasia or prostatic enlargement |
| 04/02/2002 | US6365163 Immunological tolerance-inducing agent |
| 04/02/2002 | US6365161 Molecular complex comprising two or more protein or peptide binding specificities for component on surface of antigen presenting cell, having at least one antigen linked thereto, wherein component mediates internalization of complex |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365158 Immunizing avian host with purified recombinant fusion protein comprising non-toxin protein sequence and portion of clostridium difficile toxin b sequence so as to generate neutralizing antitoxin |
| 04/02/2002 | US6365157 Angiogenesis inhibitors; antitumor agents |
| 04/02/2002 | US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane |
| 04/02/2002 | US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity |
| 04/02/2002 | US6365154 Tie2 agonist antibodies |
| 04/02/2002 | US6365151 Transfection; genetic engineering |
| 04/02/2002 | US6365138 Compositions for metabolic protection and repair of lips |
| 04/02/2002 | US6365127 Isolation of a gene encoding human thyrotropin beta subunit |
| 04/02/2002 | US6364912 Pleiotrophin-based compositions for enhancing connective tissue repair |
| 04/02/2002 | US6364893 Stent lining |
| 04/02/2002 | CA2233277C Stable extract of hypericum perforatum l., processes for its preparation and pharmaceutical compositions |
| 04/02/2002 | CA2222914C Novel cd40l mutein |
| 04/02/2002 | CA2182483C Il-3 variant hematopoiesis fusion protein |
| 04/02/2002 | CA2147875C Crf binding protein |
| 04/02/2002 | CA2086835C Tissue plasminogen activator variants with decreased clearance |
| 04/02/2002 | CA2053340C Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/02/2002 | CA1341354C Anticoagulant peptide alcohols |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/29/2002 | CA2340303A1 Rna-binding protein |
| 03/29/2002 | CA2321406A1 Restoration of perturbed barrier function by application of antiandrogens |
| 03/28/2002 | WO2002025279A2 Use of amyloid precursor protein for treating brain amyloidosis |
| 03/28/2002 | WO2002024957A1 Methods and compositions for modulating angiogenesis |
| 03/28/2002 | WO2002024932A2 Expression vectors containing hybrid ubiquitin promoters |